Ryman Healthcare Limited has provided NZX with a copy of its Annual Report for the year ended 31 March 2023.
Please see attached.
See moreThe S&P/NZX 50 Index closed at 12,266.25, gaining 57.2 points or 0.47%.
Goldman Sach analysts have a 12-month target price of A$2.85 ($3.14).
An investment firm bought the stake, which included 116,145 hectares of forestry.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details